Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101429199B details a mild two-step racemization process for fluoroquinolone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN111116531A reveals a novel one-step hydrogenation method for Ramelteon intermediates, offering superior purity and safer processing for pharmaceutical manufacturing.
Patent CN112442474B reveals a robust Fusarium oxysporum lactamase for optically pure (-) gamma-lactam production, offering superior stability and cost-effective manufacturing solutions.
Advanced preparation of Maropitant intermediates via transition metal catalysis. High purity, >99% ee, and scalable routes for pharmaceutical manufacturing.
Patent CN101289441A details a cost-effective urea-based synthesis for Carisoprodol. This method offers significant supply chain advantages and reduced manufacturing costs for API producers.
Patent CN102391243A details a novel 7-step synthesis for Atorvastatin intermediates, eliminating expensive lithium reagents and improving supply chain reliability.
Patent CN114437089A reveals a safer, high-yield route for Nalfurafine intermediate NAHY-2 using formic acid transfer hydrogenation, offering significant cost and supply chain advantages.
Patent CN113354599A reveals a safer, high-yield route for Nintedanib key intermediates using hydrazine reduction, offering significant cost reduction in API manufacturing.
Novel metal-free pyrrole synthesis patent offers high yield and reduced contamination for reliable pharmaceutical intermediate supply chains.
Patent CN103588841A details a novel ketalization method for high-purity estriol refining, offering significant cost reduction and supply chain reliability for hormone manufacturing.
Novel synthesis route for avanafil intermediate ensures high purity and safety. Cost-effective production scale-up for pharmaceutical supply chains globally seeking reliable partners.
Novel low-temperature route for erlotinib intermediates eliminates noble metals. Reduces costs and improves supply chain stability for API manufacturing.
Patent CN108101841B details a controlled hydrogenation method for Indacaterol, significantly reducing Impurity A and enhancing manufacturing efficiency for global supply chains.
Novel convergent route for Gefitinib intermediates eliminating chromatography. High yield, scalable process for pharmaceutical manufacturing supply chains.
Patent CN110143973B reveals a novel inorganic salt salification process for Flomoxef Sodium, eliminating organic acid residues and ensuring superior stability for pharmaceutical manufacturing.
Patent CN117263941B reveals a novel EGFR inhibitor synthesis with high purity and atom economy. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel patent CN120842228A offers high-yield synthesis for HIV and JAK inhibitor intermediates, ensuring cost reduction and supply chain reliability for global manufacturers.
Patent CN106423281A reveals a novel rare earth silamide catalyst for efficient spiro[cyclopropane-1,3'-indole] synthesis, offering mild conditions and cost reduction.
Novel rare earth silamide catalyzed one-pot synthesis for high-purity spiro[cyclopropane-1,3'-indole] intermediates. Cost-effective and scalable pharma manufacturing.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.